featured
Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes, Established Cardiovascular Disease, and Chronic Kidney Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Circulation
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes, Established Cardiovascular Disease and Chronic Kidney Disease
Circulation 2017 Sep 13;[EPub Ahead of Print], C Wanner, JM Lachin, SE Inzucchi, D Fitchett, M Mattheus, JT George, HJ Woerle, UC Broedl, M von Eynatten, B ZinmanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.